病毒相关性肝细胞癌的抗病毒疗法研究进展

With the development of medical technology,,the remarkable advances have been made in the therapy of hepatocellular carcinoma,The overall survival and disease-free survival of patients has been significantly prolonged.However,The recurrence rate is still high after a potentially curative treatment such as surgical interference or locoregional ablative therapie. At present, Chronic HBV/HCV infection is thought to be related with the recurrence of tumor and may take part in the process of secondary carcinogenesis.So,antiviral therapy has important implications for preventing and delaying relapse and improving the survival rate of patients with chronic virus infection after after a potentially curative treatment such as surgical interference.At the same time,virus infection has some relationship with drug resistance for the anticarcinogen ,as a result,it can reduce the effectiveness of anti-cancer drugs to some extent.therefore,antiviral therapy may play an important role in improving the effectiveness of anticarcinogen. In this article,the pathogenesis of virus -related hepatocellular carcinoma,the importance of antiviral therapy in the management of hepatocellular carcinoma and application progress of antiviral therapy were summarized